Xilio Therapeutics, Inc. ($XLO)
Brennan Kevin M. โ SVP, FINANCE AND ACCOUNTING
Shares
1,826
Price
$0.64
Total Value
$1,174.48
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Brennan Kevin M. |
|---|---|
| Title | SVP, FINANCE AND ACCOUNTING |
| Transaction Date | Jan 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 5, 2026 |
| Shares Sold | 1,826 |
| Price per Share | $0.64 |
| Total Value | $1,174.48 |
| Shares Owned After | 6,371 |
| Derivative | No |
| Accession Number | 0001193125-26-002518 |
| Document | View SEC Filing |